New York, NY [September 10, 2025]—Lung tumors don’t just evade the immune system. They reshape it at its source. Researchers from the Icahn School of Medicine at Mount Sinai and collaborators report ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

Bone marrow transplantation can be used to treat blood cell malignancies and sometimes to cure certain non-malignant blood cell disorders, but finding or creating appropriate donor bone marrow cells ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...

The From Labs to Lives Blog connects everyday topics with UC Davis research. Each post is reviewed by our experts, ensuring you always get useful information you can trust. Because we can’t see them, ...

Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...

New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing ...

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London provides valuable insights into the brain-body immune connection identifying key communication ...

Scientists uncovered how the protein Piezo1 translates physical activity into stronger bones, offering a path to exercise-mimicking therapies. Scientists from the Department of Medicine, School of ...